Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment
BeOne Medicines
BeOne Medicines
Eli Lilly and Company
Acerta Pharma BV
BeOne Medicines
Boryung Pharmaceutical Co., Ltd
Ascentage Pharma Group Inc.
Janssen Research & Development, LLC
Janssen Pharmaceutical K.K.
Taproot Health
Xencor, Inc.
BeiGene
BeiGene
X4 Pharmaceuticals
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Agenus Inc.
TG Therapeutics, Inc.
Karyopharm Therapeutics Inc
TG Therapeutics, Inc.
ADC Therapeutics S.A.
Pharmacyclics LLC.
Eli Lilly and Company
Pharmacyclics LLC.
Acrotech Biopharma Inc.
Celgene
Gilead Sciences
Takeda
Calithera Biosciences, Inc
AEterna Zentaris
Idera Pharmaceuticals, Inc.
Janssen Research & Development, LLC
GlaxoSmithKline
Amgen
Morphotek
Cellerant Therapeutics
INSYS Therapeutics Inc
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc.
Pharmacyclics LLC.
Vertex Pharmaceuticals Incorporated
MedImmune LLC